|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA Assay | Anti-Cetuximab (Erbitux®) ELISA | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) ELISA | Epstein-Barr Virus (EBNA-1) IgG ELISA | Lysozyme ELISA Assay |
| Catalog Number | IB79833 | TM09027 | TM09003 | IB79859 | IB19131 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of IgG class antibodies against Coxiella burnetii phase 1 in the early stages of infection in human serum. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Cetuximab (Erbitux®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Infliximab (Remicade®, Remsima®, and Inflectra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay for the determination of IgG-class antibodies to Epstein-Barr virus nuclear antigen type 1 (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. | Solid phase direct sandwich ELISA for the determination of Lysozyme in human plasma, serum, or stool. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | Coxiella burnetii (Q-Fever) Phase 1 IgG | sAPP Alpha | Prolactin | SCC | Human T-Cadherin(130K) |
| Sample Type | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, Blood Plasma | Serum | Human serum and EDTA-plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | Inquire | 0 / 1 - 30 ng/mL | 0 / 1 - 30 ng/mL | A cut-off control is used for the interpretation of results. | 0.1 to 40.0 ng/mL |
| Sensitivity | 88% | 0.09 ng/mL | 0.35 ng/mL | Inquire | 0.01 ng/mL |
| Assay Time | 1 hr 45 mins (incubation) | 2 hours, 15 min. total incubation time. | 2 hours, 15 min. total incubation time. | 1 hr 45 mins (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |